REVIVA PHARMACEUTCLS HLDGS I's ticker is and the CUSIP is 76152G900. A total of 4 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,030,656 | -81.7% | 211,200 | -78.0% | 0.00% | -83.3% |
| Q2 2023 | $5,620,912 | +1449.1% | 959,200 | +1007.6% | 0.02% | +1700.0% |
| Q1 2023 | $362,854 | -19.1% | 86,600 | -17.9% | 0.00% | 0.0% |
| Q4 2022 | $448,375 | +220.3% | 105,500 | +19.8% | 0.00% | – |
| Q3 2022 | $140,000 | +1900.0% | 88,100 | +1214.9% | 0.00% | – |
| Q2 2022 | $7,000 | – | 6,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,099 | $536,312 | 0.39% |
| GROUP ONE TRADING, L.P. | 211,200 | $1,030,656 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 42,800 | $208 | 0.00% |